Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
05 Setembro 2023 - 10:00AM
Business Wire
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the
“Company”) today announced that Joshua Cohen and Justin Klee,
Co-CEOs of Amylyx, will participate in the following upcoming
investor conferences in September, which are being conducted
in-person:
- H.C. Wainwright 25th Annual Global Investment Conference:
Presentation followed by Q&A on Monday, September 11, 2023, at
11:00am ET
- Morgan Stanley 21st Annual Global Healthcare Conference:
Fireside chat on Tuesday, September 12, 2023, at 3:35pm ET
A live webcast of both conference events can be accessed under
“Events and Presentations” in the Investor section of the Company’s
website, https://investors.amylyx.com/news-events/events, and will
be available for replay for 90 days following the events.
About Amylyx Pharmaceuticals
Amylyx Pharmaceuticals, Inc. is committed to supporting and
creating more moments for the neurodegenerative disease community
through the discovery and development of innovative new treatments.
Amylyx is headquartered in Cambridge, Massachusetts and has
operations in Canada and EMEA. For more information, visit
amylyx.com and follow us on LinkedIn and Twitter. For investors,
please visit investors.amylyx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230905327507/en/
Media Amylyx Media Team +1 (857) 799-7274
amylyxmediateam@amylyx.com Investors Lindsey Allen Amylyx
Pharmaceuticals, Inc. +1 (857) 320-6244 Investors@amylyx.com
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Amylyx Pharmaceuticals (NASDAQ:AMLX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024